Advertisement

Topics

Macquarie Investment Management Company Profile

10:22 EST 22nd January 2019 | BioPortfolio

Macquarie Investment Management is a global asset manager with offices throughout the United States, Europe, Asia, and Australia. As active managers, we prioritize autonomy and accountability at the team level in pursuit of opportunities that matter for clients. Our conviction-based, long-term approach has led institutional and individual clients to entrust us to manage $US253.3 billion in assets of Sept. 30, 2018. In the US, retail investors recognize our Delaware Funds by Macquarie as one of the longest-standing mutual fund families, with more than 75 years in existence. Macquarie Investment Management is a division of Macquarie Asset Management, a global asset manager with $US397.2 billion in assets under management as of Sept. 30, 2018. For more information, visit macquarieIM.com.


News Articles [977 Associated News Articles listed on BioPortfolio]

Microsoft: Einstiegsgelegenheit bei defensivem Investment!

Sydney (www.aktiencheck.de) - Microsoft-Aktienanalyse von Analystin Sarah Hindlian von Macquarie Research: Sarah Hindlian, Analystin vom Investmenthaus Macquarie Research, äußert laut einer Aktiena....

Macquarie Investment Management Urges Brookdale Senior Living Inc. Shareholders to Take Action

Macquarie Investment Management announced today that it has written an open letter to shareholders of Brookdale Senior Living Inc. (NYSE: BKD). Macquarie believes engaging with sh...

Macquarie hebt Microsoft auf 'Outperform'

Die australische Investmentbank Macquarie hat die Aktien des Software-Anbieters Microsoft von "Neutral" auf "Outperform" hochgestuft. Dies schrieb Analystin Sarah Hindlian in einer am Freitag vorl...

Macquarie hebt Ziel für Microsoft auf 125 Dollar - 'Outperform'

Die australische Investmentbank Macquarie hat das Kursziel für die Aktien des Softwarekonzerns Microsoft von 121 auf 125 US-Dollar angehoben und die Einstufung auf "Outperform" belassen. Dies schr...

Macquarie belässt Nike auf 'Outperform' - Ziel 87 US-Dollar

Die australische Investmentbank Macquarie hat die Einstufung für die Aktien des US-Sportartikelherstellers Nike auf "Outperform" mit einem Kursziel von 87 US-Dollar belassen. Dies schrieb Analyst ...

Macquarie belässt Microsoft auf 'Outperform' - Ziel 125 Dollar

Die australische Investmentbank Macquarie hat die Einstufung für Microsoft auf "Outperform" mit einem Kursziel von 125 US-Dollar belassen. Dies geht aus einer am Montag vorliegenden Studie des Ins...

Macquarie belässt Apple auf 'Outperform' - Ziel 214 Dollar

Die australische Investmentbank Macquarie hat die Einstufung für die Aktien des Computerkonzerns Apple auf "Outperform" mit einem Kursziel von 214 US-Dollar belassen. Dies schrieb Analyst Benjamin...

Macquarie belässt ExxonMobil auf 'Underperform' - Ziel 70 Dollar

Die australische Investmentbank Macquarie hat die Einstufung für ExxonMobil auf "Underperform" mit einem Kursziel von 70 US-Dollar belassen. Dies geht aus einer am Freitag vorliegenden Studie des ...

Drugs and Medications [0 Results]

None

PubMed Articles [1885 Associated PubMed Articles listed on BioPortfolio]

Uncertainty analysis of remediation cost and damaged land value for brownfield investment.

Flexible land management that allows risk-based remediation approaches can increase local financial assistance in brownfield development investments. The evaluation of brownfields investment has alway...

Investment preference promotes cooperation in spatial public goods game.

It is usually assumed that each cooperator contributes equally to different public pools in spatial public goods game. However, it is more reasonable to invest differently according to individual inve...

Integrated treatment program for alcohol related problems in community hospitals, Songkhla province of Thailand: A social return on investment analysis.

To estimate the impacts and social value relative to the cost of the Integrated Management of Alcohol Intervention Program in the Health Care System (i-MAP) on direct beneficiaries, using a Social Ret...

Can lifecycle management safeguard innovation in the pharmaceutical industry?

The pharmaceutical industry invests enormous amounts of resources (>€1 billion and >10years) in the development of new products. External factors such as intensifying foreign competition and greater...

Return on Investment: Building the Case for a Nurse Manager Certificate Program.

Nursing professional development practitioners are frequently asked about program return on investment. A pre-postprogram self-assessment was developed for a Nurse Manager Certificate Program using th...

Clinical Trials [2679 Associated Clinical Trials listed on BioPortfolio]

Determine Return on Investment in Heart Failure Remote Monitoring Program

The study will test a hypothesis that the remote monitoring with text and email alerts sent to study subject and optional family/other caregiver (Intervention 1) will have a higher return ...

Asthma and Pest Control Study: Demonstrating Return-on-Investment for In-Home Pest Control for Children With Persistent Asthma

The New York City Department of Health and Mental Hygiene and Montefiore Medical Center, with the Fund for Public Health of New York (FPHNY), DOHMH's fiscal agent, are partnering on a stud...

Mother-Child Relationships During Pregnancy Among Bofi Foragers

This study will examine changes in mother-child relationships when mothers are pregnant, because this period may involve conflicts between mothers and children. A widely held evolutionary...

Internet-Delivered Cognitive Behavior Therapy for Anxiety and Depression Amongst French Canadians

This study represents Phase II of a research program involving an international collaboration with Macquarie University (Sydney, Australia) to implement an Internet-based cognitive behavio...

Addiction Among Mental Health Professionals

Our goal is to determine the representations of addiction among caregivers working in the field of mental health. We hypothesize that caregivers, despite their investment in care, have a n...

Companies [2201 Associated Companies listed on BioPortfolio]

Macquarie Capital

Macquarie Group (Macquarie) is a global provider of banking, financial, advisory, investment and funds management services. Founded in 1969, Macquarie employs more than 14,400 peo...

Macquarie Group

Macquarie Group (ASX: MQG; ADR: MQBKY) is a leading provider of banking, financing, advisory, investment and fund management services. Founded in 1969, Macquarie Group employs mor...

Macquarie Investment Management

Macquarie Investment Management is a global asset manager with offices throughout the United States, Europe, Asia, and Australia. As active managers, we prioritize autonomy and ac...

Professor John Mathews and Dr. Hao Tan

Professor Mathews is professor of strategic management at Macquarie University in Sydney, Australia. As a specialist in technology and innovation, he is interested in the renewable energy industries a...

Investment Professionals, Inc.

Founded in 1992, IPI is a private, Texas-based investment and insurance brokerage and asset management firm with $4.2 billion under management and 45,000 clients nationwide. IPI is a leading provider...

More Information about "Macquarie Investment Management" on BioPortfolio

We have published hundreds of Macquarie Investment Management news stories on BioPortfolio along with dozens of Macquarie Investment Management Clinical Trials and PubMed Articles about Macquarie Investment Management for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of Macquarie Investment Management Companies in our database. You can also find out about relevant Macquarie Investment Management Drugs and Medications on this site too.

Advertisement
Quick Search
Advertisement
Advertisement

 

Corporate Database Quicklinks



Searches Linking to this Company Record